Home › Exocrine Pancreatic Insufficiency › California
Exocrine Pancreatic Insufficiency clinical trials in California
3 studies for Exocrine Pancreatic Insufficiency are looking for participants at sites in California.
Cities in California
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
- Keck Hospital of USC, Los Angeles
- Cedars Sinai Medical Center - Inflammatory Bowel Disease Ctr, Los Angeles
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Oct 1, 2026 · NCT07559175Phase 2 Study to Assess the Safety and Efficacy of ANG003
- Long Beach Memorial Medical Center, Long Beach
- Center for Cystic Fibrosis at Keck Medical Center of USC, Los Angeles
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 28, 2026 · NCT07450547Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency
- University of Southern California, Los Angeles
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT06477159From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.